Journal ArticleOPEN ACCESS

Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma

JACC: Case Reports (2021) 3(7) 1018-1023
DOI: 10.1016/j.jaccas.2021.04.001
7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (Level of Difficulty: Advanced.)

Author supplied keywords

Cite

CITATION STYLE

APA

Kwan, J. M., Odanovic, N., Arbune, A., Higgins, A., Henry, M., Greif, D., … Baldassarre, L. A. (2021). Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma. JACC: Case Reports, 3(7), 1018–1023. https://doi.org/10.1016/j.jaccas.2021.04.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free